Drug profile · INN
hydroxyzine hydrochloride
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — hydroxyzine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hydroxyzine hydrochloride?
hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) is a histamine h1 receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for hydroxyzine hydrochloride?
HYDROXYZINE HYDROCHLORIDE is a marketed brand name for hydroxyzine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroxyzine hydrochloride?
hydroxyzine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.